Gufic BioSciences Ltd Financials
Company Logo

Gufic BioSciences Ltd Financial Statement

Gufic BioSciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue205.40
Operating Expense178.38
Net Profit7.97
Net Profit Margin3.88
Earning Per Share0.80
EBIDTA24.50
Effective Tax Rate1.07

Gufic BioSciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual806.67
Operating Expenses Annual660.79
Operating Profit Annual148.05
Interest Annual15.36
Depreciation9.89
Net Profit Annual86.14
Tax Annual29.54

Gufic BioSciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning28.60
Cash Flow from Operations-7.46
Cash Flow from Investing-102.40
Cash Flow from Financing82.38
Cash Flow at the End1.13

Gufic BioSciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)18.35
PBIT Margin (%)16.24
PBT Margin (%)15.18
Net PROFIT Margin (%)10.68
Return On Networth / Equity (%)19.57
Return On Networth /Employed (%)16.52
Return On Assets (%)10.89
Total Debt / Equity (X)0.76
Asset Turnover Ratio (%)1.02

Gufic BioSciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual158.89
Total Current Assets Annual600.47
Non Current Assets Annual492.07
Total Shareholders Funds Annual532.56
Total Assets Annual1,092.54

Gufic BioSciences Ltd Earning Calls

EPS (INR)

Expected

0.77

Reported

0.77

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by 0.00%

FAQS on Gufic BioSciences Ltd Financials

As of Jun 7, 2025, Gufic BioSciences Ltd has a market capitalization of 3,373.84 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Gufic BioSciences Ltd is not with a debt-to-equity ratio of 0.56.

In FY 2024 , Gufic BioSciences Ltd recorded a total revenue of approximately 819.81 Cr marking a significant milestone in the company's financial performance.

Gufic BioSciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

Gufic BioSciences Ltd's current PE ratio is 48.25.

Gufic BioSciences Ltd's ROCE averaged 14.8% from the FY ending March 2023 to 2025, with a median of 15.1%. It peaked at 16.7% in March 2023, reflecting strong capital efficiency over the period..

Gufic BioSciences Ltd's latest EBIT is Rs. 117.54 Cr, surpassing the average EBIT of Rs. 121.17 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions